CG Oncology ($CGON) Insider Trading & Smart Money Activity
CG Oncology, Inc. ($CGON) has 6 insider trades and 6 13F position changes on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($350K), net -$350K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$350K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 6
- Analyst ratings on file
- 0
CGON insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $350K | 0 / 0 | 6 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CGON insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Leonard Post | Sell (Open-market sale) 10b5-1 | 5K sh | $350K | +3.2% | +0.9% | — | ||||
| Insider | Leonard Post | Buy (Option exercise) | 5K sh | $3K | +3.2% | +0.9% | — | ||||
| Insider | Leonard Post | Sell (Option exercise) | 5K sh | +11.3% | +4.6% | — | |||||
| Insider | Leonard Post | Buy (Option exercise) | 5K sh | $3K | +11.3% | +4.6% | — | ||||
| Insider | James Mulay | Sell (Option exercise) | 1.96K sh | +11.3% | +22.6% | Read | |||||
| Insider | James Mulay | Buy (Option exercise) | 1.96K sh | $18.93K | +11.3% | +22.6% | Read | ||||
| 13F | T. Rowe Price Investment Management | Added | +6.30M sh | $477.48M | -4.0% | -11.0% | Read | ||||
| 13F | Rtw Investments | Added | +4.97M sh | $416.02M | -4.0% | -11.0% | Read | ||||
| 13F | Rtw Investments | Added | +4.97M sh | $496.27M | -4.0% | -11.0% | Read | ||||
| 13F | Farallon Capital Management | Added | +666K sh | $47.89M | -4.0% | -11.0% | Read | ||||
| 13F | Caption Management | Added | +71.63K sh | $22.54M | -4.0% | -11.0% | — | ||||
| 13F | Caption Management | Added | +71.63K sh | $26.89M | -4.0% | -11.0% | Read |
1W / 1M / 6M = how CGON moved from the trade or filing date.
Insider trading in CGON: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Leonard Post | 4 | -$350K | Jun 24, 2026 | ||
| James Mulay | 2 | — | Jun 15, 2026 |
Institutions moving CGON (13F)
Frequently asked questions
Are CGON insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $350K, a net -$350K.
What is the latest insider trade in CGON?
Leonard Post filed a sell (open-market sale) of 5K sh worth $350K on Jun 24, 2026.
Which institutions changed their CGON positions?
Recent 13F filers moving the stock include Rtw Investments, Caption Management, T. Rowe Price Investment Management and Farallon Capital Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.